GlassScriptPhysician profile
Richard Shane Brown
NPI 1679538177
$122,792.06
in general payments reported to CMS, 2019-2025
18 companies · $47.96 in 2025
The $47.96 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $54K · 2020: $32K · 2021: $21K · 2022: $9,143 · 2023: $4,963 · 2024: $506 · 2025: $47.96.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $4,000 · Food and Beverage: $1,209 · Travel and Lodging: $308.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $4,000.00 |
| Food and Beverage | $1,208.74 |
| Travel and Lodging | $307.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $120,634.02 | 2019-2024 | Da Vinci Surgical System |
| Medical Device Business Services, INC. | $841.40 | 2019 | |
| W. L. Gore & Associates, INC. | $442.00 | 2023 | Gore Bio-A Fistula Plug, Gore Bio-A Tissue Reinforcement |
| Spr Therapeutics, INC | $164.62 | 2021 | |
| Davol INC. | $164.54 | 2024 | Phasix Mesh |
| Ethicon US, LLC | $125.85 | 2019 | |
| Medtronic, INC. | $60.70 | 2022 | |
| Kerecis Limited | $56.62 | 2023-2024 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Merck Sharp & Dohme LLC | $49.49 | 2019-2022 | |
| Baxter Healthcare | $45.29 | 2024-2025 | Perclot, Tisseel |
| Tela Bio, INC. | $40.49 | 2021-2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Integra Lifesciences Corporation | $29.82 | 2024 | Integra, Omnigraft, Surgimend |
| Takeda Pharmaceuticals U.S.A., INC. | $27.35 | 2023 | Gattex |
| Avanos Medical | $24.30 | 2023 | Peg |
| Stryker Corporation | $23.04 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $22.08 | 2025 | |
| Innocoll Pharmaceuticals Limited | $21.42 | 2021 | |
| Baudax Bio INC. | $19.03 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.